Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,238.9
7.0 (0.22%)

 

  • STI Straits Times Index
    3,238.9
    7.0 (0.22%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,594.8
    1.2 (0.08%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,326.7
    3.0 (0.01%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,891.3
    -18.5 (-0.64%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,303.3
    161.8 (0.70%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,128.3
    29.4 (0.48%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,162.2
    22.9 (1.07%)
    Index delayed 20 minutes
  • XAO XAO
    6,898.9
    58.1 (0.85%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,681.9M
  • Value: 1,310.8M
  • Rise: 177
  • Fall: 153
  • Unch: 499

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
SinoCloud0.001-
United Engineers2.700-0.010
YZJ Shipbldg SGD1.000+0.030
SingTel3.180-0.120
Golden Agri-Res0.255+0.010
Rex Intl0.191-0.007
China Star Food0.030+0.002
Tritech0.032+0.003
Ascendas Reit2.890-0.010
Sino Grandness0.044-

World Indices

World Indices
Name Last Change
Nasdaq 8,540.8 +61.8
HSI 26,326.7 +3.0
HSCEI 10,424.8 -2.6
Jakarta 6,128.3 +29.4
Nikkei 225 23,303.3 +161.8
SSE Comp 2,891.3 -18.5
Shanghai A 3,029.3 -19.4
Shanghai B 255.2 -3.0
PSE Comp 0.0
KOSPI 2,162.2 +22.9

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

NAVIDEA BIOPHARMACEUTICALS INC NAVIDEA BIOPHARMACEUTICALS INC
Updated on 15 Nov 2019 (End of trading day)
Last (USD): 0.688 Change: -0.021 High: 0.720 Remarks: -
Change (%): -3.02 Low: 0.680
Open 0.700 Yesterday's Close 0.7095
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 45,931 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.09961 Trailing EPS (USD) e -0.06997 NAV (USD) b -0.0047
PE a - Trailing PE f - Price / NAV b -146.4043
Dividend (USD) d - Cash In Hand (USD) g 0.0175 Issued & Paid-up Shares c 18,079,000
Dividend Yield (%) d - Price / Cash In Hand g 39.320 Treasury Shares h -
Beta - 75 Daysi 1.043 R-Squared - 75 Days(%)i 2.12 Market Cap (M) 111.615
Beta - 500 Daysi 2.106 R-Squared - 500 Days (%)i 0.06 Enterprise Value (M) 110.267
Piotroski F Score 1 Exchange Code NAVB Par Value ( $ ) n.a.
52 Weeks Volatility (%) 112.10 Free Float (%) 64.5
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 11 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference NAVIDEA BIOPHARMACEUTICALS INC NYSE American 111.615 - - -146.4043 -
Industry Biotechnology NYSE American 68.014 - - 2.4422 -
Local Peer PFENEX INC NYSE American 207.526 - - 3.7168 -
Local Peer 22ND CENTURY GROUP INC NYSE American 146.947 - - 2.6570 -
Local Peer NANOVIRICIDES INC NYSE American 135.605 - - 12.7976 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 130.321 - - - -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 120.912 3.380 2.917 - -
Local Peer MATINAS BIOPHARMA HOLDINGS INC NYSE American 95.651 - - -23.7986 -
Local Peer CEL-SCI CORP NYSE American 69.366 - - 60.5049 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 52.928 - - 515.8750 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 41.375 - - - -
Local Peer INDIA GLOBALIZATION CAPITAL INC NYSE American 23.663 - - 0.7574 -
Local Peer ORAGENICS INC NYSE American 23.937 - - 1.3365 -
Local Peer ISORAY INC NYSE American 21.325 - - - -
Other Local Peers ACTINIUM PHARMACEUTICALS INC (NYSE American), IBIO INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), AIM IMMUNOTECH INC (NYSE American)
Global Peer AMGEN INC NASDAQ 131,231.478 15.634 16.268 12.0099 2.533
Global Peer CSL ASX 124,695.694 46.478 46.478 16.6635 0.966
Global Peer GILEAD SCIENCES INC NASDAQ 82,323.311 15.091 30.569 3.9955 3.551
Global Peer CELGENE CORP NASDAQ 78,302.774 19.353 13.317 6.4783 -
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer VERTEX PHARMACEUTICAL NASDAQ 53,950.070 25.735 25.166 10.2696 -
Global Peer BIOGEN INC NASDAQ 50,933.363 11.496 9.440 3.6392 -
Global Peer ILLUMINA INC NASDAQ 44,979.795 54.455 46.228 10.1329 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 37,865.336 15.491 17.659 3.6047 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 24,218.966 76.642 22.592 5.1020 0.783
Other Global Peers ALEXION PHARMACEUTICAL INC (NASDAQ), SEATTLE GENETICS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), SINO BIOPHARM (HKEx), WUXI BIO (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), BEIGENE (HKEx), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), MODERNA INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), GENSCRIPT BIO (HKEx), REPLIGEN CORP (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), 3SBIO (HKEx), BLUEPRINT MEDICINES CORP (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), FIBROGEN INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NATERA INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), XENCOR INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), INSMED INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), HAOHAI BIOTEC (HKEx), MOMENTA PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), EPIZYME INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), VIELA BIO INC (NASDAQ), REGENXBIO INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), FRONTAGE (HKEx), ENANTA PHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), CKLIFE SCIENCES (HKEx), ARVINAS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), KARYOPHARM THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), OPKO HEALTH INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), VIVA BIOTECH (HKEx), INTREXON CORP (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), ASCENTAGE-B (HKEx), NEXTCURE INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), AVITA MEDICAL LTD (ASX), ROCKET PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), OMEROS CORP (NASDAQ), KURA ONCOLOGY INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MESOBLAST LTD (ASX), ASCLETIS-B (HKEx), RUBIUS THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), SINOMAB BIO-B (HKEx), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), TRANSLATE BIO INC (NASDAQ), XBIOTECH INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), MEIRAGTX HOLDINGS PLC (NASDAQ), AGENUS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), KADMON HLDGS INC (NYSE), PROGENICS PHARMACEUTICALS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), SYNTHORX INC (NASDAQ), IMMUNOGEN INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), ESSEX BIO-TECH (HKEx), SINOVAC BIOTECH LTD (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), AVROBIO INC (NASDAQ), DERMIRA INC (NASDAQ), MACROGENICS INC (NASDAQ), ARDELYX INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), LEXICON PHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), COMPUGEN (NASDAQ), BELLUS HEALTH INC (NASDAQ), MEDICINOVA INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), LEE'S PHARM (HKEx), HARPOON THERAPEUTICS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), PERSONALIS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), RESTORBIO INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), NEXT SCIENCE LTD (ASX), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), GERON CORP (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), SERES THERAPEUTICS (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), KAMADA (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), DPHARMA (Bursa), SYROS PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), ATHERSYS INC (NASDAQ), CHIASMA INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CUE BIOPHARMA INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), AFFIMED N V (NASDAQ), BBI LIFE SCI (HKEx), SOLID BIOSCIENCES INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), UNI-BIO GROUP (HKEx), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), ENZO BIOCHEM INC (NYSE), IVERIC BIO INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), MERSANA THERAPEUTICS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), IMV INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), SESEN BIO INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), CHIMERIX INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), NANTKWEST INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), PHYLOGICA LIMITED (ASX), AVEO PHARMACEUTICALS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), IMUGENE LIMITED (ASX), VBI VACCINES INC CDA (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), COHBAR INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), AXCELLA HEALTH INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), SYNLOGIC INC (NASDAQ), IMMUTEP LTD (ASX), VACCINEX INC (NASDAQ), VERASTEM INC (NASDAQ), TREVENA INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), VERMILLION INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), EQUILLIUM INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ORTHOCELL LIMITED (ASX), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), ORGENESIS INC (NASDAQ), CURIS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), INMUNE BIO INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), PORT (SET), CT ENTERPRISE (HKEx), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BIONOMICS LTD (ASX), EVOGENE LTD (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), ITERUM THERAPEUTICS PLC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), REGENT PACIFIC (HKEx), BIO-PATH HOLDINGS INC (NASDAQ), SAVARA INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIOTRON (ASX), ZAFGEN INC (NASDAQ), NOVITA HEALTHCARE LTD (ASX), ONCOLYTICS BIOTECH INC (NASDAQ), MEMPHASYS LTD (ASX), INVEX THERAPEUTICS LTD NPV (ASX), BIOCARDIA INC (NASDAQ), BIOSINO BIO-TEC (HKEx), RHINOMED LIMITED (ASX), CONTRAFECT CORP (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), EXTRAWELL PHAR (HKEx), MIRAGEN THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), SOLIGENIX INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), SENESTECH INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ANTEO DIAGNOSTICS LIMITED (ASX), LEAP THERAPEUTICS INC (NASDAQ), IMMURON LIMITED (ASX), BIOCEPT INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), VAXART INC (NASDAQ), TOCAGEN INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ATYR PHARMA INC (NASDAQ), PATRYS LIMITED (ASX), Suntar Eco-City^ (SGX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), CELLMID LIMITED (ASX), PRECIPIO INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), ADALTA LTD (ASX), VISTAGEN THERAPEUTICS INC (NASDAQ), REGENEUS LTD (ASX), DARE BIOSCIENCE INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), TROVAGENE INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), CONATUS PHARMACEUTICALS INC (NASDAQ), CCP TECHNOLOGIES LTD (ASX), BENITEC BIOPHARMA LTD (ASX), BENITEC BIOPHARMA LTD SPON ADS EA REPR 20 ORD SHS (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), MEGASUN (Bursa), ADVAXIS INC (NASDAQ), OCUGEN INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), AUSTRALIAN PRIMARY HEMP LTD (ASX), ARCA BIOPHARMA INC (NASDAQ), HAO WEN HLDGS (HKEx), BIOXYNE LIMITED (ASX), ENDRA LIFE SCIENCES INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), MGRC (Bursa), CAPRICOR THERAPEUTICS INC (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), TRILLIUM THERAPEUTICS INC (NASDAQ), MEDIBIO LIMITED (ASX), ACHIEVE LIFE SCIENCE INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), TBG DIAGNOSTICS LTD (ASX), XENETIC BIOSCIENCES INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), QT Vascular (SGX), AVECHO BIOTECHNOLOGY LTD (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), NANOLLOSE LTD (ASX), SPHERIX INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), BPH ENERGY LIMITED (ASX), SENECA BIOPHARMA INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), FACTOR THERAPEUTICS LIMITED (ASX), ONCONOVA THERAPEUTICS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), OPGEN INC (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.069
-9.10 %
10 Days --0.200
-22.51 %
20 Days --0.112
-13.99 %
Medium Term Return 3 Months -+0.175
+34.13 %
6 Months --0.742
-51.88 %
1 Year --3.332
-82.88 %
Long Term Return 2 Years --8.072
-92.14 %
3 Years --14.914
-95.59 %
5 Years --24.312
-97.25 %
Annualised Return Annualised --
-51.25 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.490 - 4.400 Change From 1 Year Low +0.198 % Change From 1 Year Low (%) +40.43
Change From 1 Year High -3.712 % Change From 1 Year High (%) -84.36
2 Years Range 0.490 - 9.394 Change From 2 Years Low +0.198 % Change From 2 Years Low (%) +40.43
Change From 2 Years High -8.706 % Change From 2 Years High (%) -92.68
5 Years Range 0.490 - 49.900 Change From 5 Years Low +0.198 % Change From 5 Years Low (%) +40.43
Change From 5 Years High -49.212 % Change From 5 Years High (%) -98.62
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.

Historical Price Data

Date Open High Low Close Volume VWAP
15 Nov 2019 0.700 0.720 0.680 0.688 45,931 -
14 Nov 2019 0.712 0.721 0.640 0.710 118,183 -
13 Nov 2019 0.682 0.740 0.670 0.678 193,104 -
12 Nov 2019 0.700 0.800 0.660 0.700 92,010 -
11 Nov 2019 0.760 0.784 0.706 0.733 211,739 -
08 Nov 2019 0.890 0.890 0.751 0.757 420,191 -
07 Nov 2019 0.810 0.896 0.810 0.896 150,596 -
06 Nov 2019 0.900 0.907 0.790 0.857 214,213 -
05 Nov 2019 0.924 0.970 0.888 0.900 313,953 -
04 Nov 2019 0.890 0.936 0.850 0.924 350,429 -
01 Nov 2019 0.890 0.898 0.750 0.888 941,500 -
31 Oct 2019 1.010 1.028 0.910 0.930 308,390 -
30 Oct 2019 1.060 1.060 0.902 0.970 1,764,106 -
29 Oct 2019 1.240 1.390 1.030 1.090 26,450,500 -
28 Oct 2019 0.708 0.820 0.700 0.777 156,943 -
25 Oct 2019 0.715 0.756 0.690 0.720 62,179 -
24 Oct 2019 0.770 0.780 0.690 0.715 42,847 -
23 Oct 2019 0.743 0.780 0.743 0.757 7,617 -
22 Oct 2019 0.726 0.777 0.720 0.745 28,752 -
21 Oct 2019 0.800 0.810 0.724 0.740 97,580 -
18 Oct 2019 0.820 0.830 0.760 0.800 77,711 -
17 Oct 2019 0.750 0.820 0.750 0.800 100,563 -
Summary
Current 2 Weeks
(04 Nov 2019 to 15 Nov 2019)
0.890 0.970 0.640 0.688 2,110,349 -
Previous 2 Weeks
(21 Oct 2019 to 01 Nov 2019)
0.800 0.970 0.640 0.888 29,860,414 -
4 Weeks from
(23 Sep 2019 to 18 Oct 2019)
0.890 0.970 0.640 0.800 1,385,567 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.